The combination of CDX2 expression status and tumor-infiltrating lymphocyte density as a prognostic factor in adjuvant FOLFOX-treated patients with stage III colorectal cancers.

J Pathol Transl Med · 2025 · PMC11736276 · PMID 39440351

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, the densities of CD3 iTILs and sTILs tended to be higher in CRCs with CDX2 loss than in CRCs with retained CDX2 expression, but the difference did not reach statistical significance ( Fig. 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.